Vantage logo

Pharma news over the Christmas period

If the recent performance of biotech stocks prompted you to pull down the shutters until the New Year celebrations subsided here’s what you might have missed.

Vantage logo

China comes of age

Chi-Med is not alone in seeing Chinese approval as the prelude to a regulatory green light in the west.